Retracted: Combined effects of inflammation and coronavirus disease 2019 (COVID‐19) on the risks of anxiety and depression: A cross‐sectional study based on UK Biobank

Abstract Infection‐induced perturbation of immune homeostasis could promote psychopathology. Psychiatric sequelae have been observed after previous coronavirus outbreaks. However, limited studies were conducted to explore the potential interaction effects of inflammation and coronavirus disease 2019 (COVID‐19) on the risks of anxiety and depression. In this study, first, polygenic risk scores (PRS) were calculated for eight COVID‐19 clinical phenotypes using individual‐level genotype data from the UK Biobank. Then, linear regression models were developed to assess the effects of COVID‐19 PRS, C‐reactive protein (CRP), systemic immune inflammation index (SII), and their interaction effects on the Generalized Anxiety Disorder‐7 (GAD‐7, 104 783 individuals) score and the Patient Health Questionnaire‐9 (PHQ‐9, 104 346 individuals) score. Several suggestive interactions between inflammation factors and COVID‐19 clinical phenotypes were detected for PHQ‐9 score, such as CRP/SII × Hospitalized/Not_Hospitalized in women group and CRP × Hospitalized/Unscreened in age >65 years group. For GAD‐7 score, we also found several suggestive interactions, such as CRP × Positive/Unscreened in the age ≤65 years group. Our results suggest that not only COVID‐19 and inflammation have important effects on anxiety and depression but also the interactions of COVID‐19 and inflammation have serious risks for anxiety and depression.